Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

被引:238
作者
Mukadi, YD
Maher, D
Harries, A
机构
[1] Family Hlth Int, HIV AIDS Prevent & Care Dept, Arlington, VA 22201 USA
[2] WHO, Communicable Dis Control Prevent & Eradicat Dept, CH-1211 Geneva, Switzerland
[3] Natl TB Control Programme, Lilongwe, Malawi
关键词
tuberculosis; HIV; mortality; sub-Saharan Africa;
D O I
10.1097/00002030-200101260-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Tuberculosis is a leading cause worldwide of morbidity and mortality among HIV-infected people. The HIV era has seen a dramatic increase of the tuberculosis case fatality rate (CFR) in high HIV prevalence populations. Providing care for HIV-infected people must include measures to tackle this high tuberculosis CFR. Aims: To analyse the extent of the increased tuberculosis CFR in high HIV prevalence populations in sub-Saharan Africa, the reasons for this increase and the causes of death, in order to identify possible ways of tackling this problem. Methods: References were obtained by searching the MEDLINE on 'tuberculosis', 'HIV infection', and 'mortality' (MesH or textword). In addition, available data from National Tuberculosis Programme reports were reviewed. Findings: Tuberculosis CFR is closely linked to HIV prevalence. Limited autopsy data suggest that death from HIV-related diseases other than tuberculosis is probably the main reason for the increased CFR in HIV-infected tuberculosis patients. Among HIV-infected tuberculosis patients, the higher tuberculosis CFR in sputum smear-negative and extrapulmonary than in sputum smear-positive tuberculosis cases can also be attributed to misdiagnosis of HIV-related diseases as tuberculosis. The adverse effect of the HIV/AIDS epidemic on general health service performance probably accounts for the higher tuberculosis CFR among HIV-negative tuberculosis patients in high prevalence populations than that in low HIV-prevalence populations. Conclusion: Tackling the problem of the increased tuberculosis CFR in high HIV prevalence populations requires collaboration between tuberculosis control and HIV/ AIDS programmes in implementing measures such as improved health services, tuberculosis and HIV control services, preventive treatment for HIV-related diseases and anti-HIV treatment. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 56 条
[1]   PNEUMOCYSTIS-CARINII PNEUMONIA - AN UNCOMMON CAUSE OF DEATH IN AFRICAN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
ABOUYA, YL ;
BEAUMEL, A ;
LUCAS, S ;
DAGOAKRIBI, A ;
COULIBALY, G ;
NDHATZ, M ;
KONAN, JB ;
YAPI, A ;
DECOCK, KM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03) :617-620
[2]   RESPONSE TO TREATMENT, MORTALITY, AND CD4 LYMPHOCYTE COUNTS IN HIV-INFECTED PERSONS WITH TUBERCULOSIS IN ABIDJAN, COTE-DIVOIRE [J].
ACKAH, AN ;
COULIBALY, D ;
DIGBEU, H ;
DIALLO, K ;
VETTER, KM ;
COULIBALY, IM ;
GREENBERG, AE ;
DECOCK, KM .
LANCET, 1995, 345 (8950) :607-610
[3]   Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire:: a randomised trial [J].
Anglaret, X ;
Chêne, G ;
Attia, A ;
Toure, S ;
Lafont, S ;
Combe, P ;
Manlan, K ;
N'Dri-Yoman, T ;
Salamon, R .
LANCET, 1999, 353 (9163) :1463-1468
[4]   Co-trimoxazole in HIV-1 infection [J].
Badri, M ;
Maartens, G ;
Wood, R ;
Ehrlich, R .
LANCET, 1999, 354 (9175) :334-335
[5]   HIV testing and tuberculosis treatment outcome in a rural district in Malawi [J].
Banerjee, A ;
Moyo, S ;
Salaniponi, F ;
Harries, A .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (06) :707-708
[6]  
Beaglehole R., 1993, BASIC EPIDEMIOLOGY
[7]  
BERNING SE, 1992, NEW ENGL J MED, V327, P1817, DOI 10.1056/NEJM199212173272514
[8]   A RETROSPECTIVE COHORT STUDY OF THE RISK OF TUBERCULOSIS AMONG WOMEN OF CHILDBEARING AGE WITH HIV-INFECTION IN ZAIRE [J].
BRAUN, MM ;
BADI, N ;
RYDER, RW ;
BAENDE, E ;
MUKADI, Y ;
NSUAMI, M ;
MATELA, B ;
WILLAME, JC ;
KABOTO, M ;
HEYWARD, W .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (03) :501-504
[9]  
BUHL K, 1967, B WORLD HEALTH ORGAN, V37, P907
[10]  
Connolly C, 1998, INT J TUBERC LUNG D, V2, P919